pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,878 catalysts · 4,876 phase readout · 2,342 8k filing · 286 earnings · 274 pdufa · 129 phase 2 completion · 61 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 12 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: approval×type: phase readout×type: grant×clear all
type
  • phase readout4,876
  • 8k filing2,342
  • earnings286
  • pdufa274
  • phase 2 completion129
  • phase 1 completion61
phase 1 initiation
32
  • phase 1 2 completion28
  • phase 0 trial completion22
  • phase 2 initiation16
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›RECRUITINGphase readoutNCT07352527: New Clinical Decision Support Score Based on Steroid Hormone Profiling in the Diagnosis of MACS

    Sponsor: University Hospital, Bordeaux. Phase: . Conditions: Endocrine Disease

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT05870527: Pupillary Dilation During Post-Auricular Vagal Nerve Stimulation

    Sponsor: NYU Langone Health. Phase: NA. Conditions: Hearing Loss

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06491927: Long Term Follow-up for RGX-202

    Sponsor: REGENXBIO Inc.. Phase: . Conditions: Duchenne Muscular Dystrophy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07336017: Impact on Postpartum Anal Incontinence of an Educational Program for Delivery Room Staff

    Sponsor: University Hospital, Strasbourg, France. Phase: . Conditions: Anal Incontinence

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05883540: Lysergic Acid Diethylamide (LSD) in Palliative Care

    Sponsor: University Hospital, Basel, Switzerland. Phase: PHASE2. Conditions: Palliative Care, Pain, Anxiety, Depression, Demoralization, Psychological Distress, Quality of Life, Caregiver Burden, Fear of Death, Existential Distress

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05265689: Study to Improve Adolescent Bicycling Safety

    Sponsor: Cara J. Hamann. Phase: NA. Conditions: Bicycling, Knowledge, Adolescent, Self Efficacy, Education, Attitudes, Practice, Safety, Behavior

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07499089: Together-Breast Cancer Support Platform

    Sponsor: Cedars-Sinai Medical Center. Phase: . Conditions: Breast Cancer, Breast Cancer Survivors

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07396350: IMMEDIATE IMPLANT With Different Types of Membrane

    Sponsor: Mansoura University. Phase: NA. Conditions: Tooth Extraction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07416591: Role of Saline Infusion Sonohysterography in Detection of Pelvic Adhesions in Infertile Women

    Sponsor: Sohag University. Phase: NA. Conditions: Infertile Women With Pelvic Adhesions

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07031791: PETRA: Pictorial Assessment of Task Occurrence and Upper Limb Avoidance Behaviors

    Sponsor: University Hospital, Angers. Phase: . Conditions: Thoraco-brachial Outlet Syndrome, ADAP-shoulder Scale, PETRA

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07325591: Efficacy and Safety of Tazbentetol in ALS Participants

    Sponsor: Spinogenix. Phase: PHASE2. Conditions: Amyotrophic Lateral Sclerosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07556874: Descriptive Analysis of Surgeries in Patients With Multiple Osteochondromas

    Sponsor: Istituto Ortopedico Rizzoli. Phase: . Conditions: Multiple Osteochondroma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07494318: Advanced GastroInstestinal(GI) Surgery Training in Residency and Fellowship.

    Sponsor: Methodist Health System. Phase: . Conditions: Gastro-Intestinal Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03108118: Diaphragm Injury and Dysfunction During Mechanical Ventilation

    Sponsor: University Health Network, Toronto. Phase: . Conditions: Respiratory Insufficiency, Diaphragm Injury, Mechanical Ventilation Complication

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07334197: Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy

    Sponsor: Tanta University. Phase: NA. Conditions: Ppm, Cardiomyopathy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06567860: Characterizing Late-season Influenza Vaccine Responses to Compare the 2023 and 2024 Vaccine Formulations

    Sponsor: La Jolla Institute for Immunology. Phase: PHASE4. Conditions: Influenza A

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07396220: Psychotherapy Combined With Intranasal Esketamine for the Treatment of Suicidal Ideation

    Sponsor: University of California, San Diego. Phase: NA. Conditions: Suicidal Ideation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06617182: Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.

    Sponsor: Yongquan Shi. Phase: PHASE2. Conditions: Radiation Enteritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07484724: A Study Evaluating the Safety and Efficacy of JS212 Combination Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma

    Sponsor: Shanghai Junshi Bioscience Co., Ltd.. Phase: PHASE2. Conditions: Advanced Esophageal Squamous Cell Carcinoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06628323: Neuro-VR: Augmenting a Virtual Reality-based Therapy With Biofeedback for Auditory Hallucinations

    Sponsor: University Hospital Bispebjerg and Frederiksberg. Phase: NA. Conditions: Auditory Hallucinations, Schizophrenia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07598123: Effects of Multi-component Exercise on Physical Performance and Sleep Quality in Older Adults

    Sponsor: Tunghai University. Phase: NA. Conditions: Aging, Sleep Quality, Physical Performance

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06692959: A Phase II Trial of Neoadjuvant PD-1 Vaccine PD1-Vaxx in Operable MSI High Colorectal Cancer

    Sponsor: University of Southampton. Phase: PHASE2. Conditions: Colorectal Cancer

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT02893059: Evaluation of a Data Collection Tool in Clinical Research: Comparison Between the Data Collected by Patient Diary and Data From Medical Administrative Databases

    Sponsor: Centre Hospitalier Universitaire de Nīmes. Phase: . Conditions: Case Report Form, Declaration Bias, Health Insurance Database

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04027296: Development and Validation of the GLORI-COPD Score

    Sponsor: University of Paris 5 - Rene Descartes. Phase: . Conditions: Pulmonary Disease, Chronic Obstructive

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05327296: Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU2)

    Sponsor: Sedana Medical. Phase: PHASE3. Conditions: Sedation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07504796: ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

    Sponsor: NYU Langone Health. Phase: PHASE4. Conditions: Metastatic Melanoma, Advanced Melanoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05710679: Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and Neck Cancer

    Sponsor: Centre Jean Perrin. Phase: NA. Conditions: Locally Advanced Head and Neck Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06274879: Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer

    Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: PHASE2. Conditions: Bile Duct Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06133062: Atezolizumab and Bevacizumab With Proton Radiotherapy for Unresectable Hepatocellular Carcinoma

    Sponsor: Chang Gung Memorial Hospital. Phase: PHASE2. Conditions: Hepatocellular Carcinoma Non-resectable

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07351227: Pediatric Airway: Noninferiority Trial of Devices for Intubation Assessment

    Sponsor: University of Sao Paulo General Hospital. Phase: NA. Conditions: Intubation, Intratracheal, Airway Management, Video Laryngoscope, Cost Effectiveness

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07476703: Expanded Studies on the SCAPIS Stockholm Reexamination Cohort

    Sponsor: Danderyd Hospital. Phase: . Conditions: Coronary Artery Disease, Arterial Stiffness, Blood Pressure, AORTIC VALVE DISEASES, Mitral Valve Stenosis and/or Insufficiency, Heart Failure, Pulmonary Disease, Chronic Obstructive (COPD), Steatohepatitis, Inflammation Biomarkers, Lipid Profile, Oral Microbiota, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Associated-dysfunction Steatohepatitis (MASH)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06204003: Cannabinoids for Pain Management and Neuroprotection From Concussion

    Sponsor: University of Regina. Phase: PHASE1. Conditions: Healthy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04816227: Expression Profile Study of Macrophages From Patients Affected by ALS or Other Related Motor Impairments

    Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: . Conditions: Amyotrophic Lateral Sclerosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05553327: Impact of a Multimodal Prehabilitation Program Before Robotic-assisted Radical Prostatectomy.

    Sponsor: Hospital Clinic of Barcelona. Phase: NA. Conditions: Prostate Cancer, Radical Prostatectomy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06883942: Pilot Study on the Evaluation of the Functionality, Safety and Reliability of New Tripping Devices for Lower Limbs.

    Sponsor: Fondazione Don Carlo Gnocchi ETS. Phase: . Conditions: Lower Limb Amputation, Slip Perturbations, Fall Risk

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03155386: Optimized Angiomammography and Comparison With Standard Angiomammography

    Sponsor: Gustave Roussy, Cancer Campus, Grand Paris. Phase: . Conditions: Patients for Whom an Angiomammogram Examination is Requested Whether Its Indication

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05228470: A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.

    Sponsor: Pfizer. Phase: PHASE2. Conditions: Elranatamab, Myeloma, Multiple Myeloma, Relapsed Multiple Myeloma, Refractory Multiple Myeloma, PF-06863135, BCMA, Bispecific, Bispecific Antibody, BCMA-CD3 Bispecific, MagnetisMM-8

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05748873: Promising ROd-cone DYstrophy Gene therapY

    Sponsor: SparingVision. Phase: PHASE1. Conditions: Retinitis Pigmentosa

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05471973: CIED Infection Quality Initiative Demonstration Project

    Sponsor: Duke University. Phase: NA. Conditions: Infections

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03364569: Usefullness of Peri-operative Tranexamic Acid in Primary Breast Augmentation With Implants.

    Sponsor: Hôpital NOVO. Phase: . Conditions: Plastic Surgery

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05819541: Treating Exacerbations of Asthma With Oral Montelukast in Children

    Sponsor: Vanderbilt University Medical Center. Phase: PHASE2. Conditions: Status Asthmaticus

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05228041: BIOlogics in Severe Nasal POlyposis SurvEy

    Sponsor: University Hospital, Lille. Phase: . Conditions: Chronic Rhinosinusitis With Nasal Polyps

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05515341: A DirEct to PatieNt Study in Chronic Pain

    Sponsor: Boston Scientific Corporation. Phase: . Conditions: Chronic Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07512154: Precision Radiotherapy Enabled by Molecular MRI

    Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Phase: NA. Conditions: Brain Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06273605: The Egg Up Trial - Testing a New Treatment Pathway for Infants With Newly Diagnosed Egg Allergy

    Sponsor: Murdoch Childrens Research Institute. Phase: NA. Conditions: Food Allergy, Food Allergy in Infants

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05346354: Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD

    Sponsor: Alexion Pharmaceuticals, Inc.. Phase: PHASE2. Conditions: Neuromyelitis Optica Spectrum Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05351905: Improving Pain Disability With the Use of Oral Cannabinoids

    Sponsor: University Health Network, Toronto. Phase: NA. Conditions: Chronic Pain, Opioid Use, Cannabis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07574294: Dual REmission in Moderate-to-SEvere asthMa and Nasal Polyps

    Sponsor: Azienda Ulss 2 Marca Trevigiana. Phase: . Conditions: Asthma, Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07615283: Adebrelimab Combined With SHR2554 in Relapsed/Refractory PTCL and NK/T-Cell Lymphoma

    Sponsor: Sun Yat-sen University. Phase: PHASE1. Conditions: Relapsed or Refractory Peripheral T Cell Lymphoma, NKTCL

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06585683: Post-Trial Tuberculosis Case Finding: A Substudy of CoVPN 3008

    Sponsor: COVID-19 Prevention Network. Phase: . Conditions: Tuberculosis

    full page →ctgov ↗
    ← prev
    page 87 of 98
    next →